NCT04813718View on ClinicalTrials.gov

Post COVID-19 Syndrome and the Gut-lung Axis

NAActive, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

July 11, 2022

Study Completion Date

December 31, 2024

Conditions

Covid19

Interventions

DIETARY_SUPPLEMENT

Omni-Biotic Pro Vi 5

Pre- and probiotic

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

Unknown

Medical University Graz, Graz

All Listed Sponsors

collaborator

CBmed Ges.m.b.H.

OTHER

lead

Medical University of Graz

OTHER